IGBA Builds On Partnership With WHO

Collaborating On Widening Access And Promoting Uptake

In the first in a series of exclusive interviews, IGBA chair Hanan Sboul talks about the international off-patent industry association’s collaboration with the WHO and how it is expected to develop in future.

WHO
The IGBA is strengthening its relationship with the WHO • Source: Shutterstock

When Hanan Sboul, secretary general of the Jordanian Association of Pharmaceutical Manufacturers, was appointed to take over as chair of the International Generic and Biosimilar Medicines Association for 2020, she was clear on the global off-patent industry body’s priorities.

Replacing Jim Keon – president of the Canadian Generic Pharmaceutical Association and Biosimilars Canada – who chaired the IGBA in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Generics

More from Products